Benning joined Penn in 2018. As the alliance manager for the Parker Institute for Cancer Immunotherapy at Penn (PICI@Penn), Benning works closely with PICI@Penn investigators as well as representatives from other institutions in the PICI consortium to move collaborative translational cancer immunotherapy research forward from preclinical development to clinical testing and commercial partnerships.
Prior to joining PCI, Benning worked for seven years at the Duke University Office of Licensing and Ventures managing biological material and research tool portfolio licenses and financial analysis. Before her move to the United States, Benning managed strategic biopharmaceutical infrastructure and discovery projects for the Taiwanese Ministry of Economic Affairs as part of the Promotion Plan for the Biotechnology Industry. She also served as a Law Clerk at the Civil Appeal Court in Taiwan.
Benning received an M.S. in Biochemical Sciences from National Taiwan University, an MBA from the University of North Carolina at Chapel Hill, and a L.L.B from the National Taiwan University Law School. Benning is also a Certified Licensing Professional (CLP).
